Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.095 USD | +1.14% | +3.00% | -4.04% |
May. 14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
May. 14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.04% | 217M | |
+9.23% | 114B | |
+10.15% | 105B | |
-6.11% | 23.83B | |
-1.63% | 21.73B | |
-10.51% | 18.1B | |
-42.36% | 16.34B | |
-17.91% | 16.13B | |
+3.32% | 13.75B | |
+30.33% | 11.76B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- BTIG Initiates Ovid Therapeutics With Buy Rating, Price Target is $11